Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Sören Halvard Hansen (Copenhagen, Denmark), K. Aasbjerg (Aarhus, Denmark), A. Lykkemark Møller (Hillerød, Denmark), E. Gade (Slagelse, Denmark), C. Torp-Pedersen (Hillerød, Denmark), V. Backer (Copenhagen, Denmark). Women receiving hormone replacement therapy are at high risk of developing asthma. 1430

Member's Comments

No comment yet.

Related content which might interest you: Late-breaking abstract: Postmenopausal hormone replacement therapy is associated with increased risk of asthma hospitalization Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics Year: 2011 The effects of hormone replacement therapy on pulmonary function in postmenopausal women Source: Eur Respir J 2004; 24: Suppl. 48, 574s Year: 2004 Long-term inhaled corticosteroid use in COPD and the risk of fracture in men and women Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Asthma and hayfever is associated with use of oral contraceptives and hormonal replacement therapy Source: Annual Congress 2003 - Risk factors for asthma Year: 2003 Using hormone replacement therapy in perimenopausal women with bronchial asthma (BA) Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma Year: 2007 Low risk of adrenal dysfunction in children with severe asthma treated with high-dose inhaled glucocorticoids Source: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005 Osteoporosis risk associated with chronic corticoid inhalation therapy in patients with COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Hormone replacement therapy associated with improved oxygenation in women with IPF Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Identifying patients with severe asthma that will be benefit from biological therapy Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 The influence of glucocorticoid therapy on the level of sex hormones in menopausal women with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 Combination therapy of inhaled corticosteroids and long-acting beta2-agonists may be associated with risk reduction of lung cancer in COPD patients who quit smoking Source: Eur Respir J 2006; 28: Suppl. 50, 454s Year: 2006 Characteristics of patients treated with nicotine replacement therapy (NRT) prescribed during hospitalization Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations Year: 2019 Effectiveness of combined therapy in patients with brittle asthma Source: Eur Respir J 2002; 20: Suppl. 38, 512s Year: 2002 Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma? Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 The effects of hormone therapy on pulmonary function tests in postmenopausal women Source: Eur Respir J 2004; 24: Suppl. 48, 573s Year: 2004 Combined therapy of severe osteoporosis for patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study Source: Eur Respir J, 57 (2) 2000515; 10.1183/13993003.00515-2020 Year: 2021 Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020